MedTrace Logo

Comparison Between Erythromycin and Neomycin Treatment of Hepatic Encephalopathy

NCT01097811 · Status: UNKNOWN · Phase: NA · Type: INTERVENTIONAL · Enrollment: 20

Last updated 2010-04-28

No results posted yet for this study

Summary

Comparison between the efficacy of two different antibiotics in patients with overt hepatic encephalopathy. The study is randomized, controlled and double-blinded.

Conditions

Interventions

DRUG

Erythromycin

250 mg orally q.i.d.

DRUG

Neomycin

1 g orally q.i.d.

Sponsors & Collaborators

  • Biophisics Department of Biosciences Institute - Unesp

    collaborator UNKNOWN

  • Conselho Nacional de Desenvolvimento Científico e Tecnológico

    collaborator OTHER_GOV

  • UPECLIN HC FM Botucatu Unesp

    lead OTHER

Principal Investigators

  • Fernando G Romeiro · Faculdade de Medicina de Botucatu, Unesp

  • Carlos A Caramori · Faculdade de Medicina de Botucatu, Unesp

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
DOUBLE
Model
FACTORIAL

Eligibility

Min Age
18 Years
Max Age
80 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2008-06-30
Primary Completion
2010-06-30
Completion
2010-12-31

Countries

  • Brazil

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01097811 on ClinicalTrials.gov